Fig. 2From: Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancerCytosolic free Ca2+ measurements by microspectrofluorimetry in ATC and PTC cells exposed to histone deacetylase inhibitors. Ca2+ response in Fura 2Â AM-loaded ATC (a and b) and PTC (c and d) cells after treatment with SAHA, TSA or HNHABack to article page